Jagdish A. Desai
Schering-Plough
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jagdish A. Desai.
Bioorganic & Medicinal Chemistry Letters | 1994
Anil K. Saksena; Viyyoor M. Girijavallabhan; Raymond G. Lovey; Russell E. Pike; Jagdish A. Desai; Ashit K. Ganguly; Roberta S. Hare; David Loebenberg; Anthony Cacciapuoti; Raulo Parmegiani
Abstract Sharpless-Katsuki asymmetric epoxidation of 1 provided the (R)-(+)- and (S)-(−) epoxy alcohols 2R and 2S as key intermediates towards all six stereoisomers of the title compounds. Sch 50001 and Sch 50002 (the “eutomers” of Sch 45012) are novel antifungals which display greatly improved oral activity over itraconazole and saperconazole.
Bioorganic & Medicinal Chemistry Letters | 1995
Anil K. Saksena; Viyyoor M. Girijavallabhan; Raymond G. Lovey; Jagdish A. Desai; Russell E. Pike; Edwin Jao; Haiyan Wang; Ashit K. Ganguly; David Loebenberg; Roberta S. Hare; Anthony Cacciapuoti; Raulo Parmegiani
Abstract Synthesis of Sch 51048, a novel orally active azole antifungal, is described. Based on its superior oral efficacy over other available agents against a variety of fungal pathogens in normal and immunocompromised animal infection models, Sch 51048 is a subject for possible clinical evaluation.
Heterocycles | 1993
Anil K. Saksena; Viyyoor M. Girijavallabhan; Yao-Tsung Chen; Edwin Jao; Russell E. Pike; Jagdish A. Desai; Dinanath F. Rane; Ashit K. Ganguly
Aqueous Diels-Alder reactions 1 of halogenated 2-arylfurans with acetylenedicarboxylates made available previously inaccessible adducts (2, 2a, 7, and 8) which were successfully elaborated in a general stereocontrolled route to the title compounds
Bioorganic & Medicinal Chemistry Letters | 2010
Hugh Y. Zhu; Alan B. Cooper; Jagdish A. Desai; George F Njoroge; Paul Kirschmeier; W. Robert Bishop; Corey Strickland; Alan Hruza; Ronald J. Doll; Viyyoor M. Girijavallabhan
The discovery of C-linked imidazole azaheptapyridine bridgehead FPT inhibitors is described. This novel class of compounds are sub nM FPT enzyme inhibitors with potent cellular inhibitory activities. This series also has reduced hERG activity versus previous N-linked imidazole series. X-ray of compound 10a bound to FTase revealed strong interaction between bridgehead imidazole 3N with catalytic zinc atom.
Tetrahedron Letters | 1996
Edwin Jao; Alan B. Cooper; Dinanath F. Rane; Anil K. Saksena; Jagdish A. Desai; James Wang; Viyyoor M. Girijavallabhan; Ashit K. Ganguly
Abstract A novel cyclic depsinonapeptide antifungal 1a (Sch 57697) and its isomer 1b were synthesized by a fragment coupling approach and this methodology was applied to the total synthesis of the natural product aureobasidin A. Synthetic strategies for coupling of N-methyl amino acids with minimal racemization are discussed. Biological evaluation of isomers 1a and 1b demonstrated the importance of chirality at the β-hydroxy-N-methylvaline (OHMeVal) position.
Bioorganic & Medicinal Chemistry Letters | 1993
Alan B. Cooper; Jagdish A. Desai; Raymond G. Lovey; Anil K. Saksena; Viyyoor M. Girijavallabhan; Ashit K. Ganguly; David Loebenberg; Raulo Parmegiani; Anthony Cacciapuoti
Abstract A convenient degradation of readily available polyoxin D under Edman conditions gave carboxyuracil polyoxin C 3 in high yield. Decarboxylation to uracil polyoxin C 5 (UPOC) and ring contraction to imidazolone compound 8 , gav important nikkomycin Z and X intermediates respectively. Syntheses of new polyoxin/nikkomycin analogs 12 – 27 , some with excellent chitin synthetase inhibition and Candida albicans whole cell activity are described. The importance of β-methyl substituted amino acid side chains for whole cell activity is highlighted.
Journal of The Chemical Society, Chemical Communications | 1989
Alan B. Cooper; John J. Wright; Ashit K. Ganguly; Jagdish A. Desai; David Loebenberg; Raulo Parmegiani; David S. Feingold; Inder Jit Sud
Several 14-α-aminomethyl-substituted lanosterol derivatives have been synthesized involving a complete Δ7,8to Δ8,9isomerization; these compounds are inhibitors of fungal ergosterol biosynthesis and are active against intact Candida and dermatophyte strains.
Bioorganic & Medicinal Chemistry Letters | 2002
Alan B. Cooper; Corey Strickland; James Wang; Jagdish A. Desai; Paul Kirschmeier; Robert Patton; W. Robert Bishop; Patricia C. Weber; Viyyoor M. Girijavallabhan
A series of novel N-cyanoguanidine tricyclic farnesyl protein transferase (FPT) inhibitors was prepared. Replacement of a piperidine amide-group with a N-cyanoguanidine functionality increased FPT activity. X-ray crystal structure determination of 42 complexed with FPT revealed differences in the interactions of the amide and N-cyanoguanidine groups with the protein.
Journal of Medicinal Chemistry | 1998
F. George Njoroge; Arthur G. Taveras; Joseph M. Kelly; Stacy W. Remiszewski; Alan K. Mallams; Ronald L. Wolin; Adriano Afonso; Alan B. Cooper; Dinananth F. Rane; Yi-Tsung Liu; Jesse Wong; Bancha Vibulbhan; Patrick A. Pinto; Jeffrey Deskus; Carmen Alvarez; Joycelyn del Rosario; Michael Connolly; James Wang; Jagdish A. Desai; Randall R. Rossman; W. Robert Bishop; Robert Patton; Lynn Wang; Paul Kirschmeier; Mathew S. Bryant; Amin A. Nomeir; Chuen-Horng Lin; Ming Liu; Andrew T. McPhail; Ronald J. Doll
Archive | 2006
Alan B. Cooper; Yongqi Deng; Gerald W. Shipps; Neng-Yang Shih; Hugh Y. Zhu; Robert Sun; Joseph M. Kelly; Ronald J. Doll; Yang Nan; Tong Wang; Jagdish A. Desai; James Wang; Youhao Dong; Vincent S. Madison; Li Xiao; Alan Hruza; M. Arshad Siddiqui; Ahmed A. Samatar; Sunil Paliwal; Hon-Chung Tsui; Azim A. Celebi; Yiji Wu; Sobhana Babu Boga